[Integration of the Aasalid test in an online measurement system for evaluating cerebral autoregulation].

Biomed Tech (Berl)

Institut für Biomedizinische Technik, TU Dresden, Deutschland.

Published: March 2003

An important question during the intensive care of patients with subarachnoid hemorrhage and craniocerebral trauma is the evaluation of the cerebral autoregulation (CA). The so called Aaslid-Test is a standard method which allows the cerebral autoregulation to be classified. As the results under repetitive conditions show a high variation, it has not been yet possible to draw statistically proved conclusions concerning the performance of the CA. To improve the test results the measuring conditions are discussed and systematized. The algorithms of the Aaslid-Test have been implemented to an online measuring system. The error bandwidth has been estimated. To avoid systematically occurring errors an enhanced measuring protocol is provided.

Download full-text PDF

Source
http://dx.doi.org/10.1515/bmte.2002.47.s1b.592DOI Listing

Publication Analysis

Top Keywords

cerebral autoregulation
8
[integration aasalid
4
aasalid test
4
test online
4
online measurement
4
measurement system
4
system evaluating
4
evaluating cerebral
4
cerebral autoregulation]
4
autoregulation] question
4

Similar Publications

Metabolic syndrome is a group of pathological disorders increasing the risk of serious diseases including cardiovascular disease, stroke, type 2 diabetes. Global widespread of the metabolic syndrome has put a heavy social burden. Interestingly, a crucial link between the metabolic syndrome and a psychiatric disorder may frequently coexist, in which certain shared mechanisms might play a role for the pathogenesis.

View Article and Find Full Text PDF

Background: Acute and critical neurological diseases are often accompanied with elevated intracranial pressure (ICP), leading to insufficient cerebral perfusion, which may cause severe secondary lesion. Existing ICP monitoring techniques often fail to effectively meet the demand for real-time noninvasive ICP monitoring and warning. This study aimed to explore the use of electrical impedance tomography (EIT) to provide real-time early warning of elevated ICP by observing cerebral perfusion.

View Article and Find Full Text PDF

Gut Microbiota-Bone Axis.

Ann Nutr Metab

January 2025

Department of Translational Medical Science, University of Naples Federico II, Napoli, Italy.

Background: Knowledge of the complex interplay between gut microbiota and human health is gradually increasing as it has just recently been a field of such great interest.

Summary: Recent studies have reported that communities of microorganisms inhabiting the gut influence the immune system through cellular responses and shape many physiological and pathophysiological aspects of the body, including muscle and bone metabolism (formation and resorption). Specifically, the gut microbiota affects skeletal homeostasis through changes in host metabolism, the immune system, hormone secretion, and the gut-brain axis.

View Article and Find Full Text PDF

Sleep need accumulates during waking and dissipates during sleep to maintain sleep homeostasis (process S). Besides the regulation of daily (baseline) sleep amount, homeostatic sleep regulation commonly refers to the universal phenomenon that sleep deprivation (SD) causes an increase of sleep need, hence, the amount and intensity of subsequent recovery sleep. The central regulators and signaling pathways that govern the baseline and homeostatic sleep regulations in mammals remain unclear.

View Article and Find Full Text PDF

Attenuating hyperammonemia preserves protein synthesis and muscle mass via restoration of perturbed metabolic pathways in bile duct-ligated rats.

Metab Brain Dis

January 2025

Hepato-Neuro Laboratory, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, 900, Rue Saint-Denis - Pavillon R, R08.422, Montréal (Québec), H2X 0A9, Canada.

Sarcopenia and hepatic encephalopathy (HE) are complications of chronic liver disease (CLD), which negatively impact clinical outcomes. Hyperammonemia is considered to be the central component in the pathogenesis of HE, however ammonia's toxic effects have also been shown to impinge on extracerebral organs including the muscle. Our aim was to investigate the effect of attenuating hyperammonemia with ornithine phenylacetate (OP) on muscle mass loss and associated molecular mechanisms in rats with CLD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!